We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

27 Jul 2020 07:00

RNS Number : 0748U
Location Sciences Group PLC
27 July 2020
 

Location Sciences Group PLC("Location Sciences" or the "Company")

 

Trading Update 

 

Location Sciences (AIM: LSAI), the leading location data verification company, provides the following trading update for the six months to 30 June 2020 ("H1 2020" or the "period").

 

Trading Performance

 

Unaudited revenues (including X-Mode securitisation) for the six months ended 30 June 2020 are expected to be approximately £0.65 million, an increase of approximately 43% on the corresponding period last year (H1 2019: £454,872) with core revenues (excluding X-Mode securitisation) of approximately £0.46 million, which is slightly ahead of H1 2019 despite the impact of COVID-19.

 

To mitigate the impact of COVID-19, the Company's directors implemented a cost reduction programme and are pleased to report this has seen cash administrative expenses being reduced to approximately £0.95 million for the period (H1 2019: £1.11 million), a reduction of 15%. This in turn has led to an improved adjusted cash EBITDA loss of approximately £0.68 million in the period, a decrease of approximately 17% compared to 2019 (H1 2019: EBITDA loss £0.82 million).

 

Cash Resources

 

In March 2020, the Company raised approximately £0.975 million (before expenses) through an equity placing comprising the issue and allotment of 111,430,000 new ordinary shares and an additional approximately £0.07 million was raised through the issue and allotment of 74,057,996 new ordinary shares pursuant to the issue of warrants.

 

The combination of the £1.05 million of capital raised together with the cost control measures implemented resulted in the Company having cash reserves of approximately £1.7 million at 30 June 2020 (31 December 2019: £1.3 million), which the directors believe will be sufficient for the Company's requirements until Q2 2021.

 

Impact of COVID-19

 

Verify revenues were adversely impacted by significantly reduced advertising spend in Q2 2020. In particular, it has been a challenging time for location-based advertising within sectors that rely on people's movement, such as retail and QSR. As these sectors come back to life, the Board expects a focus on local advertising which should be a positive driver for the Company's media verification revenues in H2 2020 and especially in Q4 when the Board expects the majority of the Company's Verify revenues to be secured. However, overall, the Board believes that advertising spend will be lower in 2020 compared to 2019.

 

The Company has worked hard to replace these revenues, investing significant time and energy into enlarging its data insights customer base, including making its location data available to UK Government departments and pitching for global data projects linked to the COVID-19 data analysis. Although no major contract wins have been secured to date, the Company is still exploring several open opportunities and will provide updates in due course.

 

The cash impact of the lower Verify revenues was mitigated quickly through making operational overhead cutbacks, which included reducing the Board's and senior management's remuneration.

 

Verify Progress

 

As announced in its COVID-19 update on 23 March 2020, the Company launched an updated version of its Verify Proximity platform at the end of April 2020. This will give its customers a clearer picture of how to obtain better value from their location spend and how to drive better performance. This will be needed in the months ahead, as companies look for a competitive edge.

 

In addition, Location Sciences launched its Verify Audience product in the US. Verify Audience allows brands, agencies and suppliers to check the validity of location based derived audience segments, a review of historical movements in contrast to proximity which validates the real time locations as digital advertising campaigns are delivered. To date eight paid for tests have been undertaken with the initial feedback from agencies and suppliers being very encouraging and the Company expects to be able to announce further news in the coming months.

 

X-Mode Partnership

 

The Company's partnership with X-Mode is progressing well and has allowed it to expand its insights customer base and, in particular, pitch for insight deals outside the UK as well as upsell insights to its Verify customers. This gives the Company a greater market opportunity going forward.

 

As a consequence of its partnership with X-Mode and specifically the initial transfer of some its data contracts, the Company has been required to recognise an additional approximately £0.2 million of income in H1 2020, representing the securitisation of these contracts over the period from 1 January 2020 to 31 December 2021.

 

iOS 14 - Changing the Location Landscape

 

The upcoming changes caused by iOS 14, Apple's latest iOS update due in September 2020, will see users being given the choice of sharing their IDFA (the unique identifier for advertisers) as well as an approximate location as an alternative to their precise location. This new operating system update will add greater consumer choice and transparency features that will have a significant impact on location advertisers - particularly when it comes to behavioural audiences and precise location targeting at scale.

 

The Board expects that these changes will be welcomed by consumers which will, as a result, increase the volume of location data being shared - albeit the increase in volume is likely to be driven with the sharing of approximate location (rather than not sharing at all).

 

Mark Slade, the Company's Chief Executive. commented on the impact of iOS 14 in a recent blog, which can be found via this link

https://www.locationsciences.ai/blog/ios-14-and-its-impact-on-the-location-based-advertising-market/

 

Mark Slade, Chief Executive Officer of Location Sciences, commented: "While the first half of 2020 was not what anyone had been expecting or indeed hoping for, there are some positive macro trends emerging in our industry. Only last month, Group M (the world's largest advertising agency) told its customers that location verification is critical to brand safety, a milestone which has been a long time coming and something we celebrated internally.

 

In the second half of 2020, we expect advertising revenues to return, albeit perhaps not to 2019 levels, however, with a renewed focus on local marketing, something which Location Sciences is ideally positioned to benefit from. I am confident we will emerge from this global crisis as a stronger company and better able to deliver shareholder value."

 

A further update on trading and prospects will be provided at the time of the release of the Company's unaudited interim results due to be released in mid-September 2020.

 

For further information please contact:

 

Location Sciences Group PLC

via Milk & Honey PR

Mark Slade, Chief Executive Officer

 

David Rae, CFO and Commercial Director

 

 

 

Shore Capital (Nominated Adviser and Broker)

Tel: +44 (0)20 7408 4090

 

Tom Griffiths/David Coaten

 

 

Peterhouse Capital (Joint Broker)

Charles Goodfellow

Eran Zucker

Tel: +44 (0) 20 7220 9791

 

Milk & Honey PR

Tel: +44 (0)20 3637 7310

Kirsty Leighton

 

Jessica Ballinger

 

 

About Location Sciences Group PLC:

Location Sciences is the pre-eminent global location verification provider to the $160 billion digital advertising industry. Working in partnership with brands, media agencies and suppliers to reduce ad-wastage and improve the effectiveness of location-based advertising campaigns. 

The digital advertising market-place remains unregulated and un-monitored, with an estimated $19 billion wasted on ad-fraud in 2018. Location Sciences has developed Verify, the world's first independent location verification product. Utilising sophisticated machine learning and pattern recognition technologies, Verify detects location ad-fraud and shines a light on location data inaccuracy with the aim of bringing back integrity, transparency and trust to the market place.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUSSVRRAUBUAR
Date   Source Headline
16th Feb 202412:30 pmRNSResult of General Meeting
6th Feb 202410:55 amRNSHolding(s) in Company
30th Jan 20248:00 amRNSSchedule One - Location Sciences Group Plc
30th Jan 20247:30 amRNSRestoration - Location Sciences Group PLC
30th Jan 20247:00 amRNSAcquisition and Publication of Admission Document
25th Jan 20247:00 amRNSLoan Facility and Holding in Company
20th Dec 20237:00 amRNSFurther update on proposed acquisition of Sorted
6th Oct 20237:00 amRNSUpdate on proposed acquisition of Sorted
14th Sep 20237:00 amRNSHalf-year Report
28th Jul 20231:22 pmRNSResult of AGM
25th Jul 20237:00 amRNSHolding(s) in Company
28th Jun 20237:30 amRNSSuspension - Location Sciences Group plc
28th Jun 20237:00 amRNSLoan Agreement, Proposed Acquisition & Suspension
26th Jun 20237:00 amRNSAnnual Financial Report
11th Apr 20234:56 pmRNSHolding(s) in Company
31st Mar 202311:50 amRNSHolding(s) in Company
27th Mar 20237:00 amRNSHolding(s) in Company
22nd Mar 20233:47 pmRNSHolding(s) in Company
22nd Mar 20231:40 pmRNSHolding(s) in Company
22nd Mar 20239:05 amRNSSecond Price Monitoring Extn
22nd Mar 20239:00 amRNSPrice Monitoring Extension
15th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Sep 20227:00 amRNSHalf-year Report
30th Jun 202211:56 amRNSResult of AGM
6th Jun 20227:00 amRNSNotice of Annual General Meeting
1st Jun 20222:12 pmRNSDirector/PDMR Shareholding
1st Jun 20221:25 pmRNSDirector/PDMR Shareholding
1st Jun 20227:00 amRNSBoard and strategic update
5th Apr 202211:05 amRNSSecond Price Monitoring Extn
5th Apr 202211:00 amRNSPrice Monitoring Extension
30th Mar 20227:00 amRNSAnnual Financial Report
1st Feb 20227:00 amRNSFurther re Sale of Insights dashboard
24th Jan 202211:05 amRNSSecond Price Monitoring Extn
24th Jan 202211:01 amRNSPrice Monitoring Extension
22nd Oct 20218:05 amRNSSale of Insights dashboard
27th Sep 202112:09 pmRNSHalf-year Report
21st Jun 20211:27 pmRNSBusiness Review update and proposed Board changes
21st Jun 202111:28 amRNSHolding(s) in Company
18th Jun 202110:55 amRNSResult of AGM
11th Jun 202110:34 amRNSHolding(s) in Company
8th Jun 202111:54 amRNSHolding(s) in Company
1st Jun 20219:06 amRNSSecond Price Monitoring Extn
1st Jun 20219:00 amRNSPrice Monitoring Extension
28th May 20215:00 pmRNSTotal Voting Rights
28th May 20212:11 pmRNSHolding(s) in Company
27th May 20213:33 pmRNSTR-1 Notification of major holdings
25th May 20218:05 amRNSNotice of AGM
25th May 20218:01 amRNSBoard changes and appointment of Joint Broker
21st May 202111:14 amRNSGM Result, Issue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.